WASHINGTON – Vaxin Inc. was awarded more than $2.4 million from the U.S. Department of Health & Human Services. The grant came through the National Institute of Allergy and Infectious Diseases office.
“These funds will be used to further microbiology and infectious diseases research. Vaxin Inc. is conducting vital work for our area, and I congratulate the company for securing this grant,” Congressman Spencer Bachus said.
Vaxin Inc. was awarded a cooperative agreement grant through the Challenge Grants and Partnerships Program.
###